Literature DB >> 29322795

Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study.

J Laco, H Kovarikova, M Chmelarova, H Vosmikova, K Sieglova, I Bubancova, P Dundr, K Nemejcova, J Michalek, P Celakovsky, R Mottl, I Sirak, M Vosmik, I Marek, T Geryk, J Mejzlik, J Satankova, A Ryska.   

Abstract

The aim of this study was a detailed clinicopathological investigation of sinonasal NUT midline carcinoma (NMC), including analysis of DNA methylation and microRNA (miRNA) expression. Three (5%) cases of NMC were detected among 56 sinonasal carcinomas using immunohistochemical screening and confirmed by fluorescence in situ hybridization. The series comprised 2 males and 1 female, aged 46, 60, and 65 years. Two tumors arose in the nasal cavity and one in the maxillary sinus. The neoplasms were staged pT1, pT3, and pT4a (all cN0M0). All patients were treated by radical resection with adjuvant radiotherapy. Two patients died 3 and 8 months after operation, but one patient (pT1 stage; R0 resection) experienced no evidence of disease at 108 months. Microscopically, all tumors consisted of infiltrating nests of polygonal cells with vesicular nuclei, prominent nucleoli and basophilic cytoplasm. Abrupt keratinization was present in only one case. Immunohistochemically, there was a diffuse expression of cytokeratin (CK) cocktail, CK7, p40, p63, and SMARCB1/INI1. All NMCs tested negative for EBV and HPV infection. Two NMCs showed methylation of RASSF1 gene. All other genes (APC, ATM, BRCA1, BRCA2, CADM1, CASP8, CD44, CDH13, CDKN1B, CDKN2A, CDKN2B, CHFR, DAPK1, ESR1, FHIT, GSTP1, HIC1, KLLN, MLH1a, MLH1b, RARB, TIMP3, and VHL) were unmethylated. All NMCs showed upregulation of miR-9 and downregulation of miR-99a and miR-145 and two cases featured also upregulation of miR-21, miR-143, and miR-484. In summary, we described three cases of sinonasal NMCs with novel findings on DNA methylation and miRNA expression, which might be important for new therapeutic strategies in the future.

Entities:  

Keywords:  DNA methylation; NUT midline carcinoma; RASSF1 microRNA.; sinonasal tract; t(15;19) translocation

Mesh:

Substances:

Year:  2018        PMID: 29322795     DOI: 10.4149/neo_2018_161122N581

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  5 in total

1.  MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study.

Authors:  Jan Laco; Helena Kovaříková; Marcela Chmelařová; Hana Vošmiková; Kateřina Sieglová; Ivana Baranová; Pavel Dundr; Kristýna Němejcová; Jaroslav Michálek; Jana Šatanková; Milan Vošmik; Aleš Ryška
Journal:  Virchows Arch       Date:  2018-01-11       Impact factor: 4.064

2.  MicroRNA Deregulation in Papillary Thyroid Cancer and its Relationship With BRAF V600E Mutation.

Authors:  Petr Celakovsky; Helena Kovarikova; Viktor Chrobok; Jan Mejzlik; Jan Laco; Hana Vosmikova; Marcela Chmelarova; Ales Ryska
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 3.  A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature.

Authors:  Safwan K Elkhatib; Beth K Neilsen; Richard L Sleightholm; Michael J Baine; Weining Zhen
Journal:  J Med Case Rep       Date:  2019-03-11

Review 4.  miR-484: A Potential Biomarker in Health and Disease.

Authors:  Yin-Zhao Jia; Jing Liu; Geng-Qiao Wang; Zi-Fang Song
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

5.  NUT Carcinoma in a Patient with Unusually Long Survival and False Negative FISH Results.

Authors:  Anne C McLean-Holden; Samantha A Moore; Jeffrey Gagan; Christopher A French; David Sher; John M Truelson; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2020-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.